

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 8.98709957 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 8.98709957 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.42958363 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.79913309 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.79913309 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.65477082 |
| 7 | presynaptic membrane organization (GO:0097090) | 5.44098379 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.43047424 |
| 9 | response to methylmercury (GO:0051597) | 5.29312070 |
| 10 | axon ensheathment (GO:0008366) | 5.03372455 |
| 11 | ensheathment of neurons (GO:0007272) | 5.03372455 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 4.98026815 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.98026815 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.98026815 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.98026815 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 4.98026815 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 4.98026815 |
| 18 | myelination (GO:0042552) | 4.97211915 |
| 19 | presynaptic membrane assembly (GO:0097105) | 4.96590527 |
| 20 | neuron cell-cell adhesion (GO:0007158) | 4.88087072 |
| 21 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.80514190 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.68754659 |
| 23 | fatty acid elongation (GO:0030497) | 4.64787799 |
| 24 | microglial cell activation (GO:0001774) | 4.55924752 |
| 25 | neutrophil activation involved in immune response (GO:0002283) | 4.55798759 |
| 26 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.48771081 |
| 27 | regulation of gamma-delta T cell activation (GO:0046643) | 4.45875419 |
| 28 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.45233800 |
| 29 | positive regulation of granulocyte differentiation (GO:0030854) | 4.42400842 |
| 30 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.41040626 |
| 31 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.26538990 |
| 32 | oligodendrocyte differentiation (GO:0048709) | 4.14053874 |
| 33 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.12501885 |
| 34 | myelin maintenance (GO:0043217) | 4.12349368 |
| 35 | response to lead ion (GO:0010288) | 4.07729806 |
| 36 | detection of other organism (GO:0098543) | 4.04812862 |
| 37 | macrophage activation involved in immune response (GO:0002281) | 4.00749583 |
| 38 | hepatocyte apoptotic process (GO:0097284) | 3.95067042 |
| 39 | detection of molecule of bacterial origin (GO:0032490) | 3.89920655 |
| 40 | negative thymic T cell selection (GO:0045060) | 3.89394853 |
| 41 | negative T cell selection (GO:0043383) | 3.89053212 |
| 42 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.88839145 |
| 43 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.88045929 |
| 44 | negative regulation of neurotransmitter transport (GO:0051589) | 3.87140293 |
| 45 | establishment of mitochondrion localization (GO:0051654) | 3.84962182 |
| 46 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.84762491 |
| 47 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.78190957 |
| 48 | detection of bacterium (GO:0016045) | 3.77665353 |
| 49 | positive regulation of B cell differentiation (GO:0045579) | 3.77283340 |
| 50 | B cell receptor signaling pathway (GO:0050853) | 3.75162132 |
| 51 | positive thymic T cell selection (GO:0045059) | 3.72435699 |
| 52 | detection of external biotic stimulus (GO:0098581) | 3.69189650 |
| 53 | L-amino acid import (GO:0043092) | 3.68421905 |
| 54 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.66507846 |
| 55 | cellular extravasation (GO:0045123) | 3.65887299 |
| 56 | oxygen transport (GO:0015671) | 3.65616333 |
| 57 | negative regulation of T cell mediated immunity (GO:0002710) | 3.62750218 |
| 58 | neutrophil mediated immunity (GO:0002446) | 3.62541179 |
| 59 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.61697501 |
| 60 | negative regulation of interleukin-12 production (GO:0032695) | 3.61325157 |
| 61 | response to host immune response (GO:0052572) | 3.59757654 |
| 62 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.59757654 |
| 63 | response to interleukin-15 (GO:0070672) | 3.59669115 |
| 64 | macrophage activation (GO:0042116) | 3.58730258 |
| 65 | regulation of necroptotic process (GO:0060544) | 3.58369363 |
| 66 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.56172002 |
| 67 | synaptic vesicle maturation (GO:0016188) | 3.52418067 |
| 68 | positive T cell selection (GO:0043368) | 3.52022751 |
| 69 | leukocyte aggregation (GO:0070486) | 3.50485582 |
| 70 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.50084018 |
| 71 | locomotory exploration behavior (GO:0035641) | 3.49750555 |
| 72 | neuronal action potential propagation (GO:0019227) | 3.49145862 |
| 73 | regulation of B cell differentiation (GO:0045577) | 3.44031843 |
| 74 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.43099524 |
| 75 | transmission of nerve impulse (GO:0019226) | 3.40846834 |
| 76 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.39718984 |
| 77 | hemoglobin metabolic process (GO:0020027) | 3.39210182 |
| 78 | neutrophil activation (GO:0042119) | 3.38523291 |
| 79 | glycerophospholipid catabolic process (GO:0046475) | 3.37647510 |
| 80 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.37492548 |
| 81 | response to host (GO:0075136) | 3.32894094 |
| 82 | response to host defenses (GO:0052200) | 3.32894094 |
| 83 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.32894094 |
| 84 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.32235902 |
| 85 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.31158831 |
| 86 | response to peptidoglycan (GO:0032494) | 3.30866150 |
| 87 | heme biosynthetic process (GO:0006783) | 3.30378038 |
| 88 | regulation of platelet aggregation (GO:0090330) | 3.30351673 |
| 89 | glycine transport (GO:0015816) | 3.29840263 |
| 90 | respiratory burst (GO:0045730) | 3.28776835 |
| 91 | myeloid leukocyte mediated immunity (GO:0002444) | 3.27931792 |
| 92 | postsynaptic membrane organization (GO:0001941) | 3.25293042 |
| 93 | substantia nigra development (GO:0021762) | 3.24805234 |
| 94 | myeloid cell activation involved in immune response (GO:0002275) | 3.22987735 |
| 95 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.20986060 |
| 96 | dendrite morphogenesis (GO:0048813) | 3.19650094 |
| 97 | detection of biotic stimulus (GO:0009595) | 3.18928796 |
| 98 | magnesium ion transport (GO:0015693) | 3.18197926 |
| 99 | regulation of granulocyte differentiation (GO:0030852) | 3.17841154 |
| 100 | creatine metabolic process (GO:0006600) | 3.16260468 |
| 101 | erythrocyte development (GO:0048821) | 3.16117136 |
| 102 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.12756876 |
| 103 | adult walking behavior (GO:0007628) | 3.12163835 |
| 104 | neurotransmitter uptake (GO:0001504) | 3.12079041 |
| 105 | mannosylation (GO:0097502) | 3.11171019 |
| 106 | T cell migration (GO:0072678) | 3.10316385 |
| 107 | cellular response to interleukin-15 (GO:0071350) | 3.09074017 |
| 108 | GPI anchor biosynthetic process (GO:0006506) | 3.08388830 |
| 109 | T cell selection (GO:0045058) | 3.06006265 |
| 110 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.05828736 |
| 111 | positive regulation of receptor recycling (GO:0001921) | 3.04584493 |
| 112 | granulocyte activation (GO:0036230) | 3.04372246 |
| 113 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.04092325 |
| 114 | regulation of collateral sprouting (GO:0048670) | 3.03302568 |
| 115 | regulation of mast cell degranulation (GO:0043304) | 3.02847047 |
| 116 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.02444808 |
| 117 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.01690749 |
| 118 | peptidyl-cysteine modification (GO:0018198) | 3.00078160 |
| 119 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.99738252 |
| 120 | amino acid import (GO:0043090) | 2.99365989 |
| 121 | negative regulation of necroptotic process (GO:0060546) | 2.98242996 |
| 122 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.97820995 |
| 123 | membrane tubulation (GO:0097320) | 2.97483782 |
| 124 | myeloid cell development (GO:0061515) | 2.97230145 |
| 125 | dendritic spine morphogenesis (GO:0060997) | 2.97148203 |
| 126 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.96558132 |
| 127 | gas transport (GO:0015669) | 2.95867618 |
| 128 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.93432404 |
| 129 | drug transmembrane transport (GO:0006855) | 2.92496683 |
| 130 | GPI anchor metabolic process (GO:0006505) | 2.92111695 |
| 131 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.89325711 |
| 132 | immunoglobulin mediated immune response (GO:0016064) | 2.88798521 |
| 133 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.87422320 |
| 134 | heme metabolic process (GO:0042168) | 2.85873220 |
| 135 | chaperone-mediated protein transport (GO:0072321) | 2.85452966 |
| 136 | negative regulation of axonogenesis (GO:0050771) | 2.85271320 |
| 137 | positive regulation of membrane potential (GO:0045838) | 2.84489408 |
| 138 | thymic T cell selection (GO:0045061) | 2.83908135 |
| 139 | vocalization behavior (GO:0071625) | 2.83659504 |
| 140 | type I interferon signaling pathway (GO:0060337) | 2.82468403 |
| 141 | cellular response to type I interferon (GO:0071357) | 2.82468403 |
| 142 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.81933290 |
| 143 | neuronal ion channel clustering (GO:0045161) | 2.81097214 |
| 144 | cholesterol biosynthetic process (GO:0006695) | 2.81077077 |
| 145 | leukocyte degranulation (GO:0043299) | 2.80607566 |
| 146 | response to type I interferon (GO:0034340) | 2.80111400 |
| 147 | megakaryocyte development (GO:0035855) | 2.80031829 |
| 148 | neuron remodeling (GO:0016322) | 2.78063494 |
| 149 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.76906259 |
| 150 | neuron recognition (GO:0008038) | 2.76717817 |
| 151 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.76348295 |
| 152 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.76348295 |
| 153 | lymphoid progenitor cell differentiation (GO:0002320) | 2.72780372 |
| 154 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.72124391 |
| 155 | cyclic nucleotide catabolic process (GO:0009214) | 2.72018862 |
| 156 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.70006462 |
| 157 | regulation of regulatory T cell differentiation (GO:0045589) | 2.69623818 |
| 158 | exploration behavior (GO:0035640) | 2.69583199 |
| 159 | photoreceptor cell differentiation (GO:0046530) | 2.69424503 |
| 160 | eye photoreceptor cell differentiation (GO:0001754) | 2.69424503 |
| 161 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.69075022 |
| 162 | mitochondrion transport along microtubule (GO:0047497) | 2.69075022 |
| 163 | protein localization to synapse (GO:0035418) | 2.69037596 |
| 164 | glutamate receptor signaling pathway (GO:0007215) | 2.68692487 |
| 165 | defense response to protozoan (GO:0042832) | 2.67923928 |
| 166 | response to muramyl dipeptide (GO:0032495) | 2.67019100 |
| 167 | regulation of leukocyte degranulation (GO:0043300) | 2.66102857 |
| 168 | negative regulation of adaptive immune response (GO:0002820) | 2.65680777 |
| 169 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.64884054 |
| 170 | synaptic transmission, glutamatergic (GO:0035249) | 2.64821149 |
| 171 | astrocyte development (GO:0014002) | 2.64045311 |
| 172 | tetrapyrrole biosynthetic process (GO:0033014) | 2.63560247 |
| 173 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.63473135 |
| 174 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.63031557 |
| 175 | L-phenylalanine catabolic process (GO:0006559) | 2.63031557 |
| 176 | positive regulation of synapse assembly (GO:0051965) | 2.62948111 |
| 177 | import into cell (GO:0098657) | 2.62136110 |
| 178 | negative regulation of axon extension (GO:0030517) | 2.61504873 |
| 179 | glutathione biosynthetic process (GO:0006750) | 2.61305501 |
| 180 | negative regulation of protein localization to cell surface (GO:2000009) | 2.60445435 |
| 181 | response to mercury ion (GO:0046689) | 2.60326223 |
| 182 | membrane hyperpolarization (GO:0060081) | 2.59694950 |
| 183 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.59154445 |
| 184 | regulation of pigment cell differentiation (GO:0050932) | 2.55811374 |
| 185 | protein palmitoylation (GO:0018345) | 2.55026147 |
| 186 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.54034838 |
| 187 | regulation of axon regeneration (GO:0048679) | 2.53641797 |
| 188 | regulation of neuron projection regeneration (GO:0070570) | 2.53641797 |
| 189 | C-terminal protein lipidation (GO:0006501) | 2.53607338 |
| 190 | sterol biosynthetic process (GO:0016126) | 2.53464129 |
| 191 | gamma-aminobutyric acid transport (GO:0015812) | 2.52807010 |
| 192 | auditory behavior (GO:0031223) | 2.51188966 |
| 193 | isoprenoid biosynthetic process (GO:0008299) | 2.51047004 |
| 194 | activated T cell proliferation (GO:0050798) | 2.50919396 |
| 195 | positive regulation of action potential (GO:0045760) | 2.48387716 |
| 196 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.47110163 |
| 197 | myelination in peripheral nervous system (GO:0022011) | 2.44787788 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.91803239 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.63122800 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.09387065 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.91211443 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.51933453 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.23045877 |
| 7 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.20490713 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.15646378 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.99175983 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.88145250 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.83252962 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.77843740 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.73412903 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.73295931 |
| 15 | MYB_26560356_Chip-Seq_TH2_Human | 2.72318369 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.68546546 |
| 17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.64667457 |
| 18 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.64354266 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.62419701 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.59060986 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.48756969 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.45983177 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.42474779 |
| 24 | MYB_26560356_Chip-Seq_TH1_Human | 2.37816184 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 2.36544697 |
| 26 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.35104878 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 2.33895143 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.29945023 |
| 29 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.27476606 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.26512268 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.26498105 |
| 32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.24949216 |
| 33 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.24455753 |
| 34 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.19773989 |
| 35 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.18928147 |
| 36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.17908993 |
| 37 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.16642023 |
| 38 | MYC_22102868_ChIP-Seq_BL_Human | 2.13756845 |
| 39 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.13429070 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.12798570 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.10540756 |
| 42 | UTX_26944678_Chip-Seq_JUKART_Human | 2.07306158 |
| 43 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.06518440 |
| 44 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.02956442 |
| 45 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.02136656 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.01875662 |
| 47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.01205501 |
| 48 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.00745318 |
| 49 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.99056463 |
| 50 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.96397831 |
| 51 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.95580492 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94137762 |
| 53 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.93510210 |
| 54 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.93013675 |
| 55 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.90584777 |
| 56 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.90584777 |
| 57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.90209208 |
| 58 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.85877103 |
| 59 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.84756418 |
| 60 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.83179251 |
| 61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.82634536 |
| 62 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.81138890 |
| 63 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80704760 |
| 64 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.80230622 |
| 65 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.77712798 |
| 66 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.77693965 |
| 67 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.76135573 |
| 68 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.74915911 |
| 69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.74425423 |
| 70 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.73824031 |
| 71 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.73268384 |
| 72 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.66968654 |
| 73 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.66802689 |
| 74 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.64602237 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.64321756 |
| 76 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.63857909 |
| 77 | MAF_26560356_Chip-Seq_TH2_Human | 1.61923733 |
| 78 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.61556333 |
| 79 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.60330278 |
| 80 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.56988418 |
| 81 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.56880530 |
| 82 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.52673218 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.52525193 |
| 84 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.51458396 |
| 85 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.48880934 |
| 86 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.47880805 |
| 87 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.46585172 |
| 88 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45621006 |
| 89 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.44863602 |
| 90 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.43291016 |
| 91 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.41187179 |
| 92 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40568215 |
| 93 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.40426054 |
| 94 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34364738 |
| 95 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.34259466 |
| 96 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.33958966 |
| 97 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32757939 |
| 98 | GATA1_22025678_ChIP-Seq_K562_Human | 1.32685483 |
| 99 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.31728762 |
| 100 | GATA3_26560356_Chip-Seq_TH2_Human | 1.31714707 |
| 101 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.30265468 |
| 102 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.28431904 |
| 103 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.28348922 |
| 104 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.23620286 |
| 105 | P300_19829295_ChIP-Seq_ESCs_Human | 1.23451125 |
| 106 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23435802 |
| 107 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23116679 |
| 108 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21737090 |
| 109 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.20344418 |
| 110 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.19719546 |
| 111 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.18713744 |
| 112 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.17833288 |
| 113 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17108780 |
| 114 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16883651 |
| 115 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.15269399 |
| 116 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15006557 |
| 117 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.14910339 |
| 118 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13980121 |
| 119 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.13780192 |
| 120 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.12174586 |
| 121 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.10089030 |
| 122 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10063497 |
| 123 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09471601 |
| 124 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08659688 |
| 125 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07699894 |
| 126 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07643391 |
| 127 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07101577 |
| 128 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06892222 |
| 129 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.06794775 |
| 130 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.06357767 |
| 131 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.05875417 |
| 132 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04183195 |
| 133 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.04102819 |
| 134 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.03879537 |
| 135 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03077026 |
| 136 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02971547 |
| 137 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.02001744 |
| 138 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01456396 |
| 139 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.01038617 |
| 140 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00854246 |
| 141 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97563667 |
| 142 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97267531 |
| 143 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.96990658 |
| 144 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96743503 |
| 145 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96058404 |
| 146 | * SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.95913286 |
| 147 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.95523492 |
| 148 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.94959550 |
| 149 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94820864 |
| 150 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.94696103 |
| 151 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.94430988 |
| 152 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.94259618 |
| 153 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93989427 |
| 154 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.93885760 |
| 155 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.93427546 |
| 156 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.93356280 |
| 157 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.92581089 |
| 158 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.91695451 |
| 159 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.90966501 |
| 160 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89109906 |
| 161 | FUS_26573619_Chip-Seq_HEK293_Human | 0.88173863 |
| 162 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.87002153 |
| 163 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.86178789 |
| 164 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.85260768 |
| 165 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.83592641 |
| 166 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83432196 |
| 167 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.83125171 |
| 168 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.81786116 |
| 169 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.81467487 |
| 170 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.80646069 |
| 171 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.80302580 |
| 172 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80109463 |
| 173 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79833953 |
| 174 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79568996 |
| 175 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.78261090 |
| 176 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78083359 |
| 177 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.77916875 |
| 178 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.76850564 |
| 179 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.76614978 |
| 180 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.76145763 |
| 181 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.75384448 |
| 182 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.73590366 |
| 183 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.73373767 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 4.12522848 |
| 2 | MP0004147_increased_porphyrin_level | 3.84434017 |
| 3 | MP0003880_abnormal_central_pattern | 3.69412236 |
| 4 | MP0003724_increased_susceptibility_to | 3.53873149 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.29901734 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.26085835 |
| 7 | MP0003303_peritoneal_inflammation | 3.19681582 |
| 8 | MP0004270_analgesia | 3.02333844 |
| 9 | MP0003656_abnormal_erythrocyte_physiolo | 2.98973221 |
| 10 | MP0003436_decreased_susceptibility_to | 2.96279998 |
| 11 | MP0001529_abnormal_vocalization | 2.94439016 |
| 12 | MP0005464_abnormal_platelet_physiology | 2.81593440 |
| 13 | MP0005171_absent_coat_pigmentation | 2.77538110 |
| 14 | MP0003763_abnormal_thymus_physiology | 2.66595724 |
| 15 | MP0000569_abnormal_digit_pigmentation | 2.62722688 |
| 16 | MP0002272_abnormal_nervous_system | 2.62136567 |
| 17 | MP0003635_abnormal_synaptic_transmissio | 2.57263391 |
| 18 | MP0004885_abnormal_endolymph | 2.55712743 |
| 19 | MP0003329_amyloid_beta_deposits | 2.55197404 |
| 20 | MP0005423_abnormal_somatic_nervous | 2.51956552 |
| 21 | MP0002064_seizures | 2.51636248 |
| 22 | MP0001800_abnormal_humoral_immune | 2.48316422 |
| 23 | MP0002419_abnormal_innate_immunity | 2.42694316 |
| 24 | MP0000685_abnormal_immune_system | 2.38081203 |
| 25 | MP0005409_darkened_coat_color | 2.37338280 |
| 26 | MP0001486_abnormal_startle_reflex | 2.35776329 |
| 27 | MP0009745_abnormal_behavioral_response | 2.34097337 |
| 28 | MP0005025_abnormal_response_to | 2.33647701 |
| 29 | MP0004142_abnormal_muscle_tone | 2.26631707 |
| 30 | MP0003300_gastrointestinal_ulcer | 2.23369084 |
| 31 | MP0005000_abnormal_immune_tolerance | 2.22078268 |
| 32 | MP0005451_abnormal_body_composition | 2.17753299 |
| 33 | MP0005671_abnormal_response_to | 2.17291712 |
| 34 | MP0002420_abnormal_adaptive_immunity | 2.15281086 |
| 35 | MP0002723_abnormal_immune_serum | 2.12307519 |
| 36 | MP0002398_abnormal_bone_marrow | 2.12231131 |
| 37 | MP0001819_abnormal_immune_cell | 2.12174243 |
| 38 | MP0001905_abnormal_dopamine_level | 2.09939689 |
| 39 | MP0009785_altered_susceptibility_to | 2.09644051 |
| 40 | MP0005387_immune_system_phenotype | 2.05593404 |
| 41 | MP0001790_abnormal_immune_system | 2.05593404 |
| 42 | MP0002452_abnormal_antigen_presenting | 2.03087273 |
| 43 | MP0004043_abnormal_pH_regulation | 2.01786769 |
| 44 | MP0001348_abnormal_lacrimal_gland | 1.99033888 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.94267853 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.94267853 |
| 47 | MP0003690_abnormal_glial_cell | 1.93046369 |
| 48 | MP0002405_respiratory_system_inflammati | 1.90549557 |
| 49 | MP0000778_abnormal_nervous_system | 1.90159669 |
| 50 | MP0002572_abnormal_emotion/affect_behav | 1.90060817 |
| 51 | MP0002734_abnormal_mechanical_nocicepti | 1.89631232 |
| 52 | MP0002063_abnormal_learning/memory/cond | 1.85599311 |
| 53 | MP0006082_CNS_inflammation | 1.84145453 |
| 54 | MP0009046_muscle_twitch | 1.80415971 |
| 55 | MP0000689_abnormal_spleen_morphology | 1.80247091 |
| 56 | MP0002132_abnormal_respiratory_system | 1.79521769 |
| 57 | MP0008569_lethality_at_weaning | 1.78459956 |
| 58 | MP0001968_abnormal_touch/_nociception | 1.78318931 |
| 59 | MP0002722_abnormal_immune_system | 1.78225164 |
| 60 | MP0000716_abnormal_immune_system | 1.78064469 |
| 61 | MP0003634_abnormal_glial_cell | 1.75882969 |
| 62 | MP0004742_abnormal_vestibular_system | 1.72320527 |
| 63 | MP0004381_abnormal_hair_follicle | 1.67960163 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 1.64791987 |
| 65 | MP0005645_abnormal_hypothalamus_physiol | 1.63375643 |
| 66 | MP0002166_altered_tumor_susceptibility | 1.62694252 |
| 67 | MP0002733_abnormal_thermal_nociception | 1.62636234 |
| 68 | MP0002229_neurodegeneration | 1.61332796 |
| 69 | MP0000703_abnormal_thymus_morphology | 1.61187092 |
| 70 | MP0003866_abnormal_defecation | 1.61096670 |
| 71 | MP0009333_abnormal_splenocyte_physiolog | 1.59675653 |
| 72 | MP0002735_abnormal_chemical_nociception | 1.58444090 |
| 73 | MP0002429_abnormal_blood_cell | 1.58362628 |
| 74 | MP0002067_abnormal_sensory_capabilities | 1.56964471 |
| 75 | MP0001970_abnormal_pain_threshold | 1.54010701 |
| 76 | MP0002822_catalepsy | 1.52774030 |
| 77 | MP0005075_abnormal_melanosome_morpholog | 1.52711356 |
| 78 | MP0002148_abnormal_hypersensitivity_rea | 1.51019458 |
| 79 | MP0000955_abnormal_spinal_cord | 1.48758053 |
| 80 | MP0004947_skin_inflammation | 1.48107726 |
| 81 | MP0004883_abnormal_blood_vessel | 1.47130985 |
| 82 | MP0004808_abnormal_hematopoietic_stem | 1.44413010 |
| 83 | MP0005386_behavior/neurological_phenoty | 1.42861182 |
| 84 | MP0004924_abnormal_behavior | 1.42861182 |
| 85 | MP0001845_abnormal_inflammatory_respons | 1.41874722 |
| 86 | MP0001485_abnormal_pinna_reflex | 1.40964215 |
| 87 | MP0003136_yellow_coat_color | 1.40410244 |
| 88 | MP0003828_pulmonary_edema | 1.39795931 |
| 89 | MP0005058_abnormal_lysosome_morphology | 1.38040775 |
| 90 | MP0003172_abnormal_lysosome_physiology | 1.37720586 |
| 91 | MP0002557_abnormal_social/conspecific_i | 1.37010281 |
| 92 | MP0003632_abnormal_nervous_system | 1.36927070 |
| 93 | MP0009278_abnormal_bone_marrow | 1.36210718 |
| 94 | MP0001533_abnormal_skeleton_physiology | 1.35459398 |
| 95 | MP0001440_abnormal_grooming_behavior | 1.34967632 |
| 96 | MP0010155_abnormal_intestine_physiology | 1.34376375 |
| 97 | MP0000604_amyloidosis | 1.32270096 |
| 98 | MP0005310_abnormal_salivary_gland | 1.30959784 |
| 99 | MP0002066_abnormal_motor_capabilities/c | 1.29342927 |
| 100 | MP0002736_abnormal_nociception_after | 1.29234041 |
| 101 | MP0001188_hyperpigmentation | 1.28421120 |
| 102 | MP0003631_nervous_system_phenotype | 1.28272461 |
| 103 | MP0001851_eye_inflammation | 1.26540916 |
| 104 | MP0002882_abnormal_neuron_morphology | 1.24839903 |
| 105 | MP0005646_abnormal_pituitary_gland | 1.23632792 |
| 106 | MP0000858_altered_metastatic_potential | 1.22251700 |
| 107 | MP0003633_abnormal_nervous_system | 1.22239417 |
| 108 | MP0005174_abnormal_tail_pigmentation | 1.22142060 |
| 109 | MP0005410_abnormal_fertilization | 1.21855554 |
| 110 | MP0002139_abnormal_hepatobiliary_system | 1.17017471 |
| 111 | MP0002184_abnormal_innervation | 1.16692584 |
| 112 | MP0003221_abnormal_cardiomyocyte_apopto | 1.16334958 |
| 113 | MP0004811_abnormal_neuron_physiology | 1.15208425 |
| 114 | MP0003787_abnormal_imprinting | 1.11033315 |
| 115 | MP0003879_abnormal_hair_cell | 1.10311350 |
| 116 | MP0000015_abnormal_ear_pigmentation | 1.09912380 |
| 117 | MP0001963_abnormal_hearing_physiology | 1.09775547 |
| 118 | MP0000462_abnormal_digestive_system | 1.08711904 |
| 119 | MP0002095_abnormal_skin_pigmentation | 1.08665897 |
| 120 | MP0001501_abnormal_sleep_pattern | 1.08394328 |
| 121 | MP0008469_abnormal_protein_level | 1.07223954 |
| 122 | MP0005379_endocrine/exocrine_gland_phen | 1.05493739 |
| 123 | MP0009764_decreased_sensitivity_to | 1.03285056 |
| 124 | MP0005164_abnormal_response_to | 1.02976544 |
| 125 | MP0008872_abnormal_physiological_respon | 1.01804534 |
| 126 | MP0000371_diluted_coat_color | 1.00892137 |
| 127 | MP0000631_abnormal_neuroendocrine_gland | 1.00728297 |
| 128 | MP0008057_abnormal_DNA_replication | 0.98764444 |
| 129 | MP0004134_abnormal_chest_morphology | 0.96996527 |
| 130 | MP0002332_abnormal_exercise_endurance | 0.96837617 |
| 131 | MP0003806_abnormal_nucleotide_metabolis | 0.96021492 |
| 132 | MP0002006_tumorigenesis | 0.90510265 |
| 133 | MP0009763_increased_sensitivity_to | 0.90287444 |
| 134 | MP0009379_abnormal_foot_pigmentation | 0.88375432 |
| 135 | MP0001853_heart_inflammation | 0.87106920 |
| 136 | MP0003195_calcinosis | 0.85817989 |
| 137 | MP0005408_hypopigmentation | 0.84701861 |
| 138 | MP0008260_abnormal_autophagy | 0.84459628 |
| 139 | MP0002752_abnormal_somatic_nervous | 0.84268890 |
| 140 | MP0002998_abnormal_bone_remodeling | 0.83344418 |
| 141 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83306250 |
| 142 | MP0002019_abnormal_tumor_incidence | 0.81566187 |
| 143 | MP0001502_abnormal_circadian_rhythm | 0.81038614 |
| 144 | MP0003868_abnormal_feces_composition | 0.80061443 |
| 145 | MP0005636_abnormal_mineral_homeostasis | 0.79818444 |
| 146 | MP0005535_abnormal_body_temperature | 0.79648424 |
| 147 | MP0009765_abnormal_xenobiotic_induced | 0.79537985 |
| 148 | MP0002152_abnormal_brain_morphology | 0.79150361 |
| 149 | MP0000465_gastrointestinal_hemorrhage | 0.79082529 |
| 150 | MP0003186_abnormal_redox_activity | 0.78276655 |
| 151 | MP0002938_white_spotting | 0.77502678 |
| 152 | MP0002396_abnormal_hematopoietic_system | 0.74897452 |
| 153 | MP0008004_abnormal_stomach_pH | 0.73571957 |
| 154 | MP0002069_abnormal_eating/drinking_beha | 0.72436404 |
| 155 | MP0001663_abnormal_digestive_system | 0.72174133 |
| 156 | MP0008874_decreased_physiological_sensi | 0.71297422 |
| 157 | MP0005551_abnormal_eye_electrophysiolog | 0.70303548 |
| 158 | MP0005621_abnormal_cell_physiology | 0.69827021 |
| 159 | MP0002638_abnormal_pupillary_reflex | 0.69402934 |
| 160 | MP0001915_intracranial_hemorrhage | 0.67793379 |
| 161 | MP0003183_abnormal_peptide_metabolism | 0.67522686 |
| 162 | MP0004484_altered_response_of | 0.67064405 |
| 163 | MP0000609_abnormal_liver_physiology | 0.66465226 |
| 164 | MP0006036_abnormal_mitochondrial_physio | 0.62222236 |
| 165 | MP0003075_altered_response_to | 0.61255657 |
| 166 | MP0005083_abnormal_biliary_tract | 0.61134679 |
| 167 | MP0000343_altered_response_to | 0.61084805 |
| 168 | MP0003698_abnormal_male_reproductive | 0.60964567 |
| 169 | MP0006276_abnormal_autonomic_nervous | 0.60621898 |
| 170 | MP0003091_abnormal_cell_migration | 0.60082568 |
| 171 | MP0006054_spinal_hemorrhage | 0.59685511 |
| 172 | MP0000249_abnormal_blood_vessel | 0.58414743 |
| 173 | MP0004130_abnormal_muscle_cell | 0.58173737 |
| 174 | MP0005376_homeostasis/metabolism_phenot | 0.57588669 |
| 175 | MP0001765_abnormal_ion_homeostasis | 0.57442971 |
| 176 | MP0006035_abnormal_mitochondrial_morpho | 0.57147318 |
| 177 | MP0000747_muscle_weakness | 0.56331350 |
| 178 | MP0000372_irregular_coat_pigmentation | 0.55079608 |
| 179 | MP0000026_abnormal_inner_ear | 0.54807597 |
| 180 | MP0005384_cellular_phenotype | 0.54269309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypochromic microcytic anemia (HP:0004840) | 6.02497939 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.54666035 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.52012843 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.31595207 |
| 5 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.56845705 |
| 6 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.52155879 |
| 7 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.52155879 |
| 8 | Myositis (HP:0100614) | 4.35333337 |
| 9 | Cerebral hypomyelination (HP:0006808) | 4.22526558 |
| 10 | Prolonged bleeding time (HP:0003010) | 4.21190321 |
| 11 | Neurofibrillary tangles (HP:0002185) | 4.21122816 |
| 12 | Peripheral hypomyelination (HP:0007182) | 4.16321130 |
| 13 | T lymphocytopenia (HP:0005403) | 4.14694352 |
| 14 | Microcytic anemia (HP:0001935) | 4.06361054 |
| 15 | Gastrointestinal infarctions (HP:0005244) | 4.06337222 |
| 16 | Orchitis (HP:0100796) | 4.02023064 |
| 17 | Abnormality of the corticospinal tract (HP:0002492) | 4.01271029 |
| 18 | Hypochromic anemia (HP:0001931) | 4.01070818 |
| 19 | Abnormality of macrophages (HP:0004311) | 3.97268017 |
| 20 | Gingival bleeding (HP:0000225) | 3.95615495 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.92649444 |
| 22 | Abnormality of T cell number (HP:0011839) | 3.89236615 |
| 23 | Recurrent fungal infections (HP:0002841) | 3.84913050 |
| 24 | Retrobulbar optic neuritis (HP:0100654) | 3.82853206 |
| 25 | Optic neuritis (HP:0100653) | 3.82853206 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.81118559 |
| 27 | Stomatitis (HP:0010280) | 3.72647789 |
| 28 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.71008498 |
| 29 | Ankle clonus (HP:0011448) | 3.67630591 |
| 30 | Spontaneous hematomas (HP:0007420) | 3.63375283 |
| 31 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.60339239 |
| 32 | Recurrent skin infections (HP:0001581) | 3.54726357 |
| 33 | Retinal dysplasia (HP:0007973) | 3.53761766 |
| 34 | Supranuclear gaze palsy (HP:0000605) | 3.46956084 |
| 35 | Epistaxis (HP:0000421) | 3.46843390 |
| 36 | Metabolic alkalosis (HP:0200114) | 3.45815660 |
| 37 | Abnormal auditory evoked potentials (HP:0006958) | 3.45010691 |
| 38 | Spastic gait (HP:0002064) | 3.40032482 |
| 39 | Increased circulating renin level (HP:0000848) | 3.35864979 |
| 40 | Myokymia (HP:0002411) | 3.34040237 |
| 41 | Gingivitis (HP:0000230) | 3.32055781 |
| 42 | Urticaria (HP:0001025) | 3.31582627 |
| 43 | Chronic obstructive pulmonary disease (HP:0006510) | 3.30915054 |
| 44 | Obstructive lung disease (HP:0006536) | 3.30915054 |
| 45 | Type II lissencephaly (HP:0007260) | 3.25507874 |
| 46 | Mediastinal lymphadenopathy (HP:0100721) | 3.24285740 |
| 47 | * Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.23845544 |
| 48 | Hypokalemic alkalosis (HP:0001949) | 3.22752270 |
| 49 | Hypomagnesemia (HP:0002917) | 3.20804497 |
| 50 | Meningitis (HP:0001287) | 3.17819358 |
| 51 | Polycythemia (HP:0001901) | 3.17394538 |
| 52 | Onion bulb formation (HP:0003383) | 3.16668323 |
| 53 | Encephalitis (HP:0002383) | 3.13372495 |
| 54 | Recurrent viral infections (HP:0004429) | 3.10319586 |
| 55 | Abnormality of T cells (HP:0002843) | 3.04446827 |
| 56 | Recurrent cutaneous fungal infections (HP:0011370) | 2.98469696 |
| 57 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.98469696 |
| 58 | Petechiae (HP:0000967) | 2.96842639 |
| 59 | Keratoconjunctivitis sicca (HP:0001097) | 2.93198981 |
| 60 | Intention tremor (HP:0002080) | 2.93016235 |
| 61 | CNS hypomyelination (HP:0003429) | 2.91019190 |
| 62 | Cellulitis (HP:0100658) | 2.87818430 |
| 63 | Vasculitis (HP:0002633) | 2.86715752 |
| 64 | Chest pain (HP:0100749) | 2.84796684 |
| 65 | Leukocytosis (HP:0001974) | 2.84017662 |
| 66 | Peritonitis (HP:0002586) | 2.83944684 |
| 67 | Abnormality of magnesium homeostasis (HP:0004921) | 2.80622481 |
| 68 | Inflammation of the large intestine (HP:0002037) | 2.78602311 |
| 69 | Akinesia (HP:0002304) | 2.78113095 |
| 70 | Spastic paraparesis (HP:0002313) | 2.77607555 |
| 71 | White forelock (HP:0002211) | 2.74839791 |
| 72 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.71260786 |
| 73 | Cerebral inclusion bodies (HP:0100314) | 2.70782939 |
| 74 | Gastrointestinal inflammation (HP:0004386) | 2.70652432 |
| 75 | Arterial thrombosis (HP:0004420) | 2.69465188 |
| 76 | Limb dystonia (HP:0002451) | 2.69154898 |
| 77 | Abnormal platelet volume (HP:0011876) | 2.65947934 |
| 78 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.65735405 |
| 79 | Leukodystrophy (HP:0002415) | 2.65373349 |
| 80 | Keratoconjunctivitis (HP:0001096) | 2.63963422 |
| 81 | Dysmetria (HP:0001310) | 2.63636331 |
| 82 | Sensory axonal neuropathy (HP:0003390) | 2.62193489 |
| 83 | Patchy hypopigmentation of hair (HP:0011365) | 2.61689574 |
| 84 | Granulocytopenia (HP:0001913) | 2.59889990 |
| 85 | Cholelithiasis (HP:0001081) | 2.58205343 |
| 86 | Osteomyelitis (HP:0002754) | 2.49637953 |
| 87 | Morphological abnormality of the inner ear (HP:0011390) | 2.49543083 |
| 88 | Episodic fever (HP:0001954) | 2.45290428 |
| 89 | Panhypogammaglobulinemia (HP:0003139) | 2.45194832 |
| 90 | Focal motor seizures (HP:0011153) | 2.45160334 |
| 91 | Acute hepatic failure (HP:0006554) | 2.43579663 |
| 92 | Increased IgE level (HP:0003212) | 2.41228829 |
| 93 | Autoimmune hemolytic anemia (HP:0001890) | 2.41179932 |
| 94 | Broad-based gait (HP:0002136) | 2.40951794 |
| 95 | Orthostatic hypotension (HP:0001278) | 2.40360882 |
| 96 | Alacrima (HP:0000522) | 2.39095348 |
| 97 | Scanning speech (HP:0002168) | 2.37253850 |
| 98 | Parakeratosis (HP:0001036) | 2.36919097 |
| 99 | Pustule (HP:0200039) | 2.35987187 |
| 100 | Insidious onset (HP:0003587) | 2.35582852 |
| 101 | Termporal pattern (HP:0011008) | 2.35582852 |
| 102 | Colitis (HP:0002583) | 2.34237594 |
| 103 | Viral hepatitis (HP:0006562) | 2.33311560 |
| 104 | Chronic otitis media (HP:0000389) | 2.32517909 |
| 105 | Abnormal drinking behavior (HP:0030082) | 2.32065469 |
| 106 | Polydipsia (HP:0001959) | 2.32065469 |
| 107 | Choreoathetosis (HP:0001266) | 2.31918592 |
| 108 | Anorexia (HP:0002039) | 2.30560785 |
| 109 | Action tremor (HP:0002345) | 2.30382619 |
| 110 | Abnormality of iron homeostasis (HP:0011031) | 2.29902175 |
| 111 | Muscular hypotonia of the trunk (HP:0008936) | 2.27202358 |
| 112 | Abnormal gallbladder morphology (HP:0012437) | 2.27179675 |
| 113 | Abnormality of T cell physiology (HP:0011840) | 2.27111222 |
| 114 | Eosinophilia (HP:0001880) | 2.26198982 |
| 115 | Progressive inability to walk (HP:0002505) | 2.25709923 |
| 116 | Increased IgM level (HP:0003496) | 2.22908735 |
| 117 | Purpura (HP:0000979) | 2.21990956 |
| 118 | Pulmonary infiltrates (HP:0002113) | 2.21596033 |
| 119 | Hemoptysis (HP:0002105) | 2.19519035 |
| 120 | Clonus (HP:0002169) | 2.18867842 |
| 121 | Increased mean platelet volume (HP:0011877) | 2.18512732 |
| 122 | Recurrent bronchitis (HP:0002837) | 2.15923322 |
| 123 | Pulmonary embolism (HP:0002204) | 2.15361387 |
| 124 | Decreased lacrimation (HP:0000633) | 2.14649845 |
| 125 | Polyuria (HP:0000103) | 2.14301993 |
| 126 | Ocular albinism (HP:0001107) | 2.14125026 |
| 127 | Increased serum ferritin (HP:0003281) | 2.13727017 |
| 128 | Paraparesis (HP:0002385) | 2.12311940 |
| 129 | Fatigue (HP:0012378) | 2.12281211 |
| 130 | Abnormality of the fingertips (HP:0001211) | 2.12165703 |
| 131 | Subacute progressive viral hepatitis (HP:0006572) | 2.11982592 |
| 132 | Abnormality of the peritoneum (HP:0002585) | 2.11022131 |
| 133 | Thyroid-stimulating hormone excess (HP:0002925) | 2.08651866 |
| 134 | Abnormal hemoglobin (HP:0011902) | 2.08457357 |
| 135 | Clumsiness (HP:0002312) | 2.08026379 |
| 136 | Acanthocytosis (HP:0001927) | 2.06516659 |
| 137 | Anxiety (HP:0000739) | 2.05398111 |
| 138 | Urinary urgency (HP:0000012) | 2.02842661 |
| 139 | Poikilocytosis (HP:0004447) | 2.02581021 |
| 140 | Toxemia of pregnancy (HP:0100603) | 2.01874537 |
| 141 | Lymphopenia (HP:0001888) | 2.01145862 |
| 142 | Epileptic encephalopathy (HP:0200134) | 2.00967347 |
| 143 | Mutism (HP:0002300) | 2.00622337 |
| 144 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.00575789 |
| 145 | Conjunctival telangiectasia (HP:0000524) | 1.99449567 |
| 146 | Hyperaldosteronism (HP:0000859) | 1.99300178 |
| 147 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.99050087 |
| 148 | IgM deficiency (HP:0002850) | 1.98423666 |
| 149 | Poor speech (HP:0002465) | 1.98299683 |
| 150 | Agammaglobulinemia (HP:0004432) | 1.97537967 |
| 151 | Lissencephaly (HP:0001339) | 1.97337237 |
| 152 | Hypothermia (HP:0002045) | 1.97196165 |
| 153 | Abnormal platelet function (HP:0011869) | 1.95721618 |
| 154 | Impaired platelet aggregation (HP:0003540) | 1.95721618 |
| 155 | Alkalosis (HP:0001948) | 1.95648194 |
| 156 | Abnormality of eosinophils (HP:0001879) | 1.94410345 |
| 157 | Craniofacial dystonia (HP:0012179) | 1.93539683 |
| 158 | Autoimmune thrombocytopenia (HP:0001973) | 1.93193485 |
| 159 | Hyperbilirubinemia (HP:0002904) | 1.92634209 |
| 160 | Thrombophlebitis (HP:0004418) | 1.92446510 |
| 161 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.91630030 |
| 162 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.91457004 |
| 163 | Hypoplasia of the brainstem (HP:0002365) | 1.91457004 |
| 164 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91449020 |
| 165 | Abnormal number of erythroid precursors (HP:0012131) | 1.90333711 |
| 166 | Albinism (HP:0001022) | 1.89559139 |
| 167 | Abnormality of renin-angiotensin system (HP:0000847) | 1.88267884 |
| 168 | Premature skin wrinkling (HP:0100678) | 1.88116877 |
| 169 | Cutaneous photosensitivity (HP:0000992) | 1.87947975 |
| 170 | Abnormal urine output (HP:0012590) | 1.87508737 |
| 171 | Hyperventilation (HP:0002883) | 1.86531229 |
| 172 | Spastic tetraparesis (HP:0001285) | 1.85132308 |
| 173 | Psychosis (HP:0000709) | 1.84385473 |
| 174 | Focal dystonia (HP:0004373) | 1.84081564 |
| 175 | Delayed epiphyseal ossification (HP:0002663) | 1.83744990 |
| 176 | Progressive neurologic deterioration (HP:0002344) | 1.81548259 |
| 177 | Torticollis (HP:0000473) | 1.81148530 |
| 178 | Focal seizures (HP:0007359) | 1.80823172 |
| 179 | Megalencephaly (HP:0001355) | 1.80750080 |
| 180 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.79810170 |
| 181 | Blue irides (HP:0000635) | 1.79786075 |
| 182 | Delayed myelination (HP:0012448) | 1.78766362 |
| 183 | Renal Fanconi syndrome (HP:0001994) | 1.78720530 |
| 184 | Visual hallucinations (HP:0002367) | 1.78412716 |
| 185 | Truncal ataxia (HP:0002078) | 1.77464672 |
| 186 | Polyphagia (HP:0002591) | 1.76382185 |
| 187 | Partial agenesis of the corpus callosum (HP:0001338) | 1.76099186 |
| 188 | Absent speech (HP:0001344) | 1.76032694 |
| 189 | Lower limb muscle weakness (HP:0007340) | 1.72432385 |
| 190 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.71897333 |
| 191 | Cerebellar dysplasia (HP:0007033) | 1.71874716 |
| 192 | Diaphragmatic weakness (HP:0009113) | 1.70679764 |
| 193 | Insomnia (HP:0100785) | 1.70647533 |
| 194 | Hypoplastic pelvis (HP:0008839) | 1.70364231 |
| 195 | * Rigidity (HP:0002063) | 1.70058960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 4.88341181 |
| 2 | RIPK4 | 4.39722787 |
| 3 | STK39 | 3.76936494 |
| 4 | OXSR1 | 3.59513297 |
| 5 | MARK1 | 3.48933466 |
| 6 | GRK6 | 3.47824899 |
| 7 | MAP2K3 | 3.37865069 |
| 8 | CDK19 | 2.88825080 |
| 9 | MAP4K1 | 2.84423837 |
| 10 | BLK | 2.61943353 |
| 11 | MAPKAPK5 | 2.48096181 |
| 12 | FES | 2.47561575 |
| 13 | CASK | 2.33287374 |
| 14 | PRPF4B | 2.22127922 |
| 15 | TYK2 | 2.20129231 |
| 16 | PKN1 | 2.20123692 |
| 17 | CSK | 2.19351822 |
| 18 | WNK4 | 2.19143103 |
| 19 | MAP3K3 | 2.16958786 |
| 20 | IKBKE | 2.12997723 |
| 21 | IRAK4 | 2.11696880 |
| 22 | CSNK1G3 | 2.09380969 |
| 23 | DYRK2 | 2.03389034 |
| 24 | JAK3 | 2.01376610 |
| 25 | UHMK1 | 2.00230808 |
| 26 | TAOK1 | 1.99015218 |
| 27 | MAPK13 | 1.97311324 |
| 28 | EPHB1 | 1.95205902 |
| 29 | MUSK | 1.89582949 |
| 30 | CSNK1G2 | 1.75183262 |
| 31 | NTRK2 | 1.74207655 |
| 32 | ZAP70 | 1.73789518 |
| 33 | ERN1 | 1.72813266 |
| 34 | PTK2B | 1.69344719 |
| 35 | TAOK2 | 1.68551621 |
| 36 | TXK | 1.66669127 |
| 37 | CSNK1A1L | 1.65925763 |
| 38 | TYRO3 | 1.54577598 |
| 39 | MAP3K14 | 1.53464470 |
| 40 | MAP3K1 | 1.51696587 |
| 41 | CSNK1G1 | 1.48601908 |
| 42 | HCK | 1.46444366 |
| 43 | MARK3 | 1.42244472 |
| 44 | GRK5 | 1.37759571 |
| 45 | WNK3 | 1.35948297 |
| 46 | STK4 | 1.31223618 |
| 47 | ICK | 1.29341023 |
| 48 | PIM1 | 1.28591652 |
| 49 | LYN | 1.28307803 |
| 50 | JAK2 | 1.26647332 |
| 51 | EPHA4 | 1.25469957 |
| 52 | FGFR3 | 1.24514155 |
| 53 | BMPR2 | 1.22929511 |
| 54 | TNK2 | 1.22306072 |
| 55 | MAP2K7 | 1.21540129 |
| 56 | JAK1 | 1.20415031 |
| 57 | CDK5 | 1.19610139 |
| 58 | TLK1 | 1.17850785 |
| 59 | IRAK2 | 1.17568786 |
| 60 | TEC | 1.14113860 |
| 61 | MARK2 | 1.13871508 |
| 62 | NEK6 | 1.13828596 |
| 63 | ITK | 1.12020196 |
| 64 | SGK2 | 1.09780390 |
| 65 | KSR2 | 1.05612745 |
| 66 | CAMK2B | 1.05577687 |
| 67 | SGK3 | 1.04566067 |
| 68 | NTRK3 | 1.03473894 |
| 69 | KIT | 1.03435652 |
| 70 | TBK1 | 1.01523791 |
| 71 | MATK | 1.00131080 |
| 72 | SGK494 | 0.99823120 |
| 73 | SGK223 | 0.99823120 |
| 74 | LIMK1 | 0.99255400 |
| 75 | LRRK2 | 0.99229171 |
| 76 | MINK1 | 0.99086513 |
| 77 | SIK2 | 0.98611503 |
| 78 | CLK1 | 0.98388579 |
| 79 | BCR | 0.96423825 |
| 80 | RAF1 | 0.94266545 |
| 81 | PIK3CG | 0.93935564 |
| 82 | YES1 | 0.91701896 |
| 83 | FGFR4 | 0.91557434 |
| 84 | WNK1 | 0.89535972 |
| 85 | VRK1 | 0.88523558 |
| 86 | PHKG2 | 0.88402170 |
| 87 | PHKG1 | 0.88402170 |
| 88 | NTRK1 | 0.86653000 |
| 89 | IKBKB | 0.86512781 |
| 90 | MAP3K5 | 0.85595238 |
| 91 | STK10 | 0.85180956 |
| 92 | FGFR2 | 0.84969686 |
| 93 | STK16 | 0.83625639 |
| 94 | PAK6 | 0.80860560 |
| 95 | CSF1R | 0.79653559 |
| 96 | SIK3 | 0.79627504 |
| 97 | PDK1 | 0.76235276 |
| 98 | ROCK2 | 0.74747153 |
| 99 | PNCK | 0.74017386 |
| 100 | IRAK1 | 0.71283238 |
| 101 | CAMK2G | 0.68874456 |
| 102 | MAP3K6 | 0.67629573 |
| 103 | PLK2 | 0.67556951 |
| 104 | HIPK2 | 0.67294000 |
| 105 | MAP3K4 | 0.67175161 |
| 106 | PTK6 | 0.65279423 |
| 107 | CDK14 | 0.64191308 |
| 108 | KSR1 | 0.64150401 |
| 109 | CAMK2D | 0.64116893 |
| 110 | NLK | 0.63997565 |
| 111 | TGFBR2 | 0.63993205 |
| 112 | PINK1 | 0.63082101 |
| 113 | BMX | 0.61416949 |
| 114 | TRPM7 | 0.61020373 |
| 115 | CDK12 | 0.60087956 |
| 116 | BMPR1B | 0.59676692 |
| 117 | CDK15 | 0.59274058 |
| 118 | CAMK1 | 0.59071334 |
| 119 | EIF2AK1 | 0.58979768 |
| 120 | SCYL2 | 0.58731756 |
| 121 | CAMK2A | 0.58697776 |
| 122 | CDK18 | 0.57553693 |
| 123 | FGR | 0.57380474 |
| 124 | CDK11A | 0.55528831 |
| 125 | STK38 | 0.54794088 |
| 126 | ERBB2 | 0.53910767 |
| 127 | FYN | 0.52960073 |
| 128 | PDPK1 | 0.52634103 |
| 129 | SYK | 0.52532204 |
| 130 | MAP3K7 | 0.51744619 |
| 131 | MAPK4 | 0.51689643 |
| 132 | CAMKK2 | 0.50666515 |
| 133 | MET | 0.50537764 |
| 134 | GRK7 | 0.50049683 |
| 135 | TESK2 | 0.47696989 |
| 136 | PRKCQ | 0.46779880 |
| 137 | SMG1 | 0.46155954 |
| 138 | DYRK1A | 0.45241378 |
| 139 | MAPK12 | 0.44138384 |
| 140 | PDGFRB | 0.43592400 |
| 141 | DYRK1B | 0.43189938 |
| 142 | CDK4 | 0.41914939 |
| 143 | DAPK2 | 0.41583294 |
| 144 | TRIB3 | 0.41153016 |
| 145 | MAP3K10 | 0.39964214 |
| 146 | MAPK11 | 0.39500876 |
| 147 | BTK | 0.38990906 |
| 148 | ADRBK2 | 0.38963034 |
| 149 | LCK | 0.38653973 |
| 150 | PRKCZ | 0.38554874 |
| 151 | CCNB1 | 0.38281130 |
| 152 | PBK | 0.38108712 |
| 153 | MAPK15 | 0.37328475 |
| 154 | PRKG1 | 0.37322185 |
| 155 | SGK1 | 0.36729100 |
| 156 | INSRR | 0.36572554 |
| 157 | STK11 | 0.36327496 |
| 158 | MAP3K11 | 0.35774478 |
| 159 | PRKCG | 0.33721055 |
| 160 | FLT3 | 0.33345998 |
| 161 | EGFR | 0.32791058 |
| 162 | TAOK3 | 0.32172099 |
| 163 | MAP3K12 | 0.32081849 |
| 164 | ACVR1B | 0.30064274 |
| 165 | PRKCH | 0.30041944 |
| 166 | CSNK1D | 0.29061994 |
| 167 | MAP3K2 | 0.28847165 |
| 168 | GSK3A | 0.28528434 |
| 169 | RET | 0.28349394 |
| 170 | MAP3K13 | 0.27619671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.09229843 |
| 2 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.09854467 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.06617254 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.79828226 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.76420820 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.70841356 |
| 7 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.70119914 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.60313281 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.60141960 |
| 10 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.52928834 |
| 11 | Protein export_Homo sapiens_hsa03060 | 2.40390812 |
| 12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.29387780 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.26717167 |
| 14 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.20711988 |
| 15 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.19374258 |
| 16 | Malaria_Homo sapiens_hsa05144 | 2.17492389 |
| 17 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 2.14420844 |
| 18 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.08937753 |
| 19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.02690933 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.98002368 |
| 21 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.97193637 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.96643355 |
| 23 | GABAergic synapse_Homo sapiens_hsa04727 | 1.95072892 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.94694906 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.93398670 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.89837200 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.89381428 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.84587632 |
| 29 | Allograft rejection_Homo sapiens_hsa05330 | 1.83281069 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.76717518 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.76673161 |
| 32 | Nicotine addiction_Homo sapiens_hsa05033 | 1.76422667 |
| 33 | Axon guidance_Homo sapiens_hsa04360 | 1.75369176 |
| 34 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.75052116 |
| 35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.73242985 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.72907139 |
| 37 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.72315982 |
| 38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.72055130 |
| 39 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.70055780 |
| 40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.68079672 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.62521948 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.60422063 |
| 43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.57642685 |
| 44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.57308681 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.56223632 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.56212952 |
| 47 | Morphine addiction_Homo sapiens_hsa05032 | 1.56104999 |
| 48 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.54417197 |
| 49 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.52521637 |
| 50 | Platelet activation_Homo sapiens_hsa04611 | 1.51855344 |
| 51 | Parkinsons disease_Homo sapiens_hsa05012 | 1.51473537 |
| 52 | Circadian entrainment_Homo sapiens_hsa04713 | 1.50763415 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.49875253 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49581321 |
| 55 | Influenza A_Homo sapiens_hsa05164 | 1.48441024 |
| 56 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.46987302 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46276121 |
| 58 | Hepatitis B_Homo sapiens_hsa05161 | 1.43362553 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.39944324 |
| 60 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.37797295 |
| 61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.36568006 |
| 62 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.35567143 |
| 63 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.32286853 |
| 64 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.32227472 |
| 65 | Legionellosis_Homo sapiens_hsa05134 | 1.31492624 |
| 66 | Apoptosis_Homo sapiens_hsa04210 | 1.26008499 |
| 67 | Long-term depression_Homo sapiens_hsa04730 | 1.25934233 |
| 68 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.23897459 |
| 69 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.23252141 |
| 70 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.22707833 |
| 71 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.22416543 |
| 72 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.22299825 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.21936336 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 1.20673550 |
| 75 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.19391541 |
| 76 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.17886529 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.16140520 |
| 78 | Sulfur relay system_Homo sapiens_hsa04122 | 1.15825602 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.15797505 |
| 80 | Alzheimers disease_Homo sapiens_hsa05010 | 1.15462646 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.14741375 |
| 82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.14216340 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 1.13547267 |
| 84 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.13110713 |
| 85 | Alcoholism_Homo sapiens_hsa05034 | 1.12854481 |
| 86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.11682601 |
| 87 | Olfactory transduction_Homo sapiens_hsa04740 | 1.10279019 |
| 88 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09691602 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.07820604 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.06626374 |
| 91 | Salivary secretion_Homo sapiens_hsa04970 | 1.04667544 |
| 92 | Phagosome_Homo sapiens_hsa04145 | 1.03442320 |
| 93 | Histidine metabolism_Homo sapiens_hsa00340 | 1.01287289 |
| 94 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.00887903 |
| 95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00503851 |
| 96 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.00456875 |
| 97 | Peroxisome_Homo sapiens_hsa04146 | 1.00226469 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.99787761 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.97701422 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.96108588 |
| 101 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.95450027 |
| 102 | Shigellosis_Homo sapiens_hsa05131 | 0.94994060 |
| 103 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.94795165 |
| 104 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.93591080 |
| 105 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92901915 |
| 106 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.90899267 |
| 107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.89837534 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.89105060 |
| 109 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87456540 |
| 110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86874941 |
| 111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.86450431 |
| 112 | Long-term potentiation_Homo sapiens_hsa04720 | 0.85113191 |
| 113 | Thyroid cancer_Homo sapiens_hsa05216 | 0.84368231 |
| 114 | Insulin secretion_Homo sapiens_hsa04911 | 0.83805645 |
| 115 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.81342782 |
| 116 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.77458282 |
| 117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.77064054 |
| 118 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.77003097 |
| 119 | Asthma_Homo sapiens_hsa05310 | 0.76975158 |
| 120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76274364 |
| 121 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.74154406 |
| 122 | ABC transporters_Homo sapiens_hsa02010 | 0.72479581 |
| 123 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72279745 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69992090 |
| 125 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.69227449 |
| 126 | Colorectal cancer_Homo sapiens_hsa05210 | 0.68254591 |
| 127 | Renin secretion_Homo sapiens_hsa04924 | 0.67572619 |
| 128 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.67251625 |
| 129 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.66872708 |
| 130 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66861549 |
| 131 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66794898 |
| 132 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.66536176 |
| 133 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66281272 |
| 134 | Salmonella infection_Homo sapiens_hsa05132 | 0.66144627 |
| 135 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66100958 |
| 136 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.65440541 |
| 137 | Pertussis_Homo sapiens_hsa05133 | 0.64575971 |
| 138 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.64561273 |
| 139 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.63905937 |
| 140 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63875188 |
| 141 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.63369428 |
| 142 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61071269 |
| 143 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.60488242 |
| 144 | Taste transduction_Homo sapiens_hsa04742 | 0.60117640 |
| 145 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59977697 |
| 146 | Prostate cancer_Homo sapiens_hsa05215 | 0.59128606 |
| 147 | Glioma_Homo sapiens_hsa05214 | 0.58156623 |
| 148 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57239939 |
| 149 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56279892 |
| 150 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55757430 |
| 151 | Other glycan degradation_Homo sapiens_hsa00511 | 0.54618619 |
| 152 | Gap junction_Homo sapiens_hsa04540 | 0.54478671 |
| 153 | Insulin resistance_Homo sapiens_hsa04931 | 0.50717920 |
| 154 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.48803175 |
| 155 | Ribosome_Homo sapiens_hsa03010 | 0.48118529 |
| 156 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.47722224 |
| 157 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47294780 |
| 158 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.46916012 |
| 159 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46440642 |
| 160 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45339317 |
| 161 | Endocytosis_Homo sapiens_hsa04144 | 0.45053162 |
| 162 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.44895920 |
| 163 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44492108 |
| 164 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44030118 |
| 165 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43498515 |
| 166 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43340415 |
| 167 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.43158932 |
| 168 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42904205 |
| 169 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.41430581 |
| 170 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41359895 |
| 171 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.40930360 |
| 172 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.40745996 |
| 173 | Huntingtons disease_Homo sapiens_hsa05016 | 0.40350943 |
| 174 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.39822825 |
| 175 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.39517269 |
| 176 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.38456240 |
| 177 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37358658 |
| 178 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36407405 |
| 179 | Bile secretion_Homo sapiens_hsa04976 | 0.35552524 |
| 180 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.34606463 |
| 181 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.34199043 |
| 182 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.33170470 |
| 183 | Lysosome_Homo sapiens_hsa04142 | 0.29489076 |
| 184 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.29330721 |
| 185 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.27127650 |
| 186 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.22579376 |
| 187 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22364477 |

